301 related articles for article (PubMed ID: 34182228)
1. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.
de Oliveira Cardoso JM; de Brito RCF; Costa AFP; Siqueira Mathias FA; Soares Reis LE; Vieira JFP; de Oliveira Aguiar Soares RD; Reis AB; Roatt BM
Mol Immunol; 2021 Sep; 137():20-27. PubMed ID: 34182228
[TBL] [Abstract][Full Text] [Related]
2. Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis.
Costa SF; Gomes VO; Dos Santos Maciel MO; Melo LM; Venturin GL; Bragato JP; Rebech GT; de Oliveira Santos C; Nascimento de Oliveira BM; Gileno de Sá Oliveira G; Felix de Lima VM
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008021. PubMed ID: 31961868
[TBL] [Abstract][Full Text] [Related]
3. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
[TBL] [Abstract][Full Text] [Related]
4. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with a CD4
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
[TBL] [Abstract][Full Text] [Related]
7. Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function.
Esch KJ; Juelsgaard R; Martinez PA; Jones DE; Petersen CA
J Immunol; 2013 Dec; 191(11):5542-50. PubMed ID: 24154626
[TBL] [Abstract][Full Text] [Related]
8. Detection of intracellular IFN-γ and IL-4 cytokines in CD4+ and CD8+ T cells in the peripheral blood of dogs naturally infected with Leishmania infantum.
Matralis D; Papadogiannakis E; Kontos V; Papadopoulos E; Ktenas E; Koutinas A
Parasite Immunol; 2016 Aug; 38(8):510-5. PubMed ID: 27153749
[TBL] [Abstract][Full Text] [Related]
9. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
[TBL] [Abstract][Full Text] [Related]
10. CD4
Vieira JFP; de Oliveira Cardoso JM; de Brito RCF; Roatt BM; Carneiro CM; Valadares DG; de Oliveira Aguiar-Soares RD; Reis AB
Mol Immunol; 2022 Nov; 151():61-69. PubMed ID: 36087461
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Cardoso JMO; Brito RCF; Mathias FAS; Reis LES; Vieira JFP; Ostolin TLVDP; Andrade HM; Ramos GS; Frézard F; Aguiar-Soares RDO; Roatt BM; Reis AB
Mol Immunol; 2022 Jan; 141():70-78. PubMed ID: 34814056
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.
Carrillo E; Ahmed S; Goldsmith-Pestana K; Nieto J; Osorio Y; Travi B; Moreno J; McMahon-Pratt D
Vaccine; 2007 Feb; 25(8):1534-43. PubMed ID: 17178178
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells, Cytotoxic T lymphocytes and a T(H)1 cytokine profile in dogs naturally infected by Leishmania infantum.
Cortese L; Annunziatella M; Palatucci AT; Rubino V; Piantedosi D; Di Loria A; Ruggiero G; Ciaramella P; Terrazzano G
Res Vet Sci; 2013 Dec; 95(3):942-9. PubMed ID: 24079840
[TBL] [Abstract][Full Text] [Related]
14. Expression of regulatory T cells in jejunum, colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania infantum.
Figueiredo MM; Deoti B; Amorim IF; Pinto AJ; Moraes A; Carvalho CS; da Silva SM; de Assis AC; de Faria AM; Tafuri WL
Infect Immun; 2014 Sep; 82(9):3704-12. PubMed ID: 24935975
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
16. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
17. IL-15 in human visceral leishmaniasis caused by Leishmania infantum.
Milano S; Di Bella G; D'Agostino P; Barbera C; Caruso R; La Rosa M; Ferlazzo V; Vitale G; La Russa C; Gambino G; Chifari N; Mansueto S; Cillari E
Clin Exp Immunol; 2002 Feb; 127(2):360-5. PubMed ID: 11876762
[TBL] [Abstract][Full Text] [Related]
18. T cells, adhesion molecules and modulation of apoptosis in visceral leishmaniasis glomerulonephritis.
Costa FA; Prianti MG; Silva TC; Silva SM; Guerra JL; Goto H
BMC Infect Dis; 2010 May; 10():112. PubMed ID: 20459816
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs.
Sanchez-Robert E; Altet L; Alberola J; Rodriguez-Cortés A; Ojeda A; López-Fuertes L; Timon M; Sanchez A; Francino O
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):168-75. PubMed ID: 18514330
[TBL] [Abstract][Full Text] [Related]
20. Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
Martins VT; Chávez-Fumagalli MA; Costa LE; Canavaci AM; Martins AM; Lage PS; Lage DP; Duarte MC; Valadares DG; Magalhães RD; Ribeiro TG; Nagem RA; Darocha WD; Régis WC; Soto M; Coelho EA; Fernandes AP; Tavares CA
PLoS Negl Trop Dis; 2013; 7(3):e2148. PubMed ID: 23573301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
